AMEH
Undervalued by 122.4% based on the discounted cash flow analysis.
Market cap | $2.38 Billion |
---|---|
Enterprise Value | $2.31 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.91 |
Beta | 1.55 |
Outstanding Shares | 58,283,589 |
Avg 30 Day Volume | 175,324 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 56.8 |
---|---|
PEG | -375.89 |
Price to Sales | 1.86 |
Price to Book Ratio | 4.08 |
Enterprise Value to Revenue | 1.74 |
Enterprise Value to EBIT | 22.75 |
Enterprise Value to Net Income | 48 |
Total Debt to Enterprise | 0.09 |
Debt to Equity | 0.36 |
No data
No data
ApolloMed is a leading physician-centric, technology-enabled healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcar...